Clinical Study of Non Severe Aplastic Anemia Treated With Cyclosporine, Androgen and Levamisole
The clinical symptoms of non transfusion dependent non severe
The clinical symptoms of non transfusion dependent non severe
To evaluate the hematological responses based on the response assessment criteria when AMG531 is subcutaneous (SC)-administered with anti-human thymocyte immunoglobulin (ATG) + ciclosporin A (CsA) therapy for 6 months in patients with
Graduated in Medicine (1997) and PhD in Clinical Medicine (2003) from the Ribeirão Preto Medical School of the University of São Paulo (FMRP-USP) and medical residency in Hematology and Hemotherapy (2001) from the Hospital das Clinicas of FMRP-USP. He did postdoctoral studies at the National Institutes of Health, Bethesda, Maryland, USA, where he also worked as a Staff Scientist at the Hematology Branch until 2011.
Dr. Litzow is Professor of Medicine in the Division of Hematology at Mayo Clinic in Rochester, Minnesota. He was the Director of the BMT Program at Mayo from 1992 to 2008 and continues to remain active in the BMT program. He was the Director of the Myeloid Disease Oriented Group in the Division of Hematology from 2002 to 2016. He was appointed chair of the Leukemia Committee of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network (ECOG-ACRIN) in September 2013 after having served as co-chair of the committee since 2001.
Maxim Norkin, MD, PhD, is board certified in hematology and oncology with clinical expertise in hematological malignancies and bone marrow transplantation. An advisory group member of the National Marrow Donor Program, Dr.
Dr. Nimer has been conducting extensive clinical and basic science research into the treatment, and genetic basis of adult leukemia and
September 16 through December 20 will stand out in Ashley’s mind.
Forever.
These are the days she spent in the hospital with her feisty three-year-old, Alayna, for conditioning and bone marrow transplant.